Literature DB >> 22553440

Accumulation of trospectomycin by strains of Salmonella typhimurium, Escherichia coli and Haemophilus influenzae.

S Wong1, L Bryan.   

Abstract

Trospectomycin, unlike aminoglycosidic aminocyclitols, is accumulated by a nonsaturable, energy-independent, diffusional process in Salmonella typhimurium, Escherichia coli and Haemophilus influenzae. A deep rough mutant of S typhimurium was more susceptible and accumulated the drug faster, and F porin deficient mutants of E coli were more resistant than parental strains. Trospectomycin likely uses both porin and nonporin pathways to cross the outer membrane. An E coli strain effectively accumulated the drug anaerobically, explaining its anaerobic activity. An H influenzae strain accumulated trospectomycin at concentrations below those for which detectable uptake could be observed with E coli or S typhimurium strains, consistent with greater activity in Haemophilus species.

Entities:  

Keywords:  Aminocyclitols; Trospectomycin; Uptake

Year:  1990        PMID: 22553440      PMCID: PMC3327961          DOI: 10.1155/1990/258273

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  11 in total

Review 1.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

2.  Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.

Authors:  N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

3.  In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.

Authors:  G E Zurenko; B H Yagi; J J Vavra; B B Wentworth
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

4.  Endogenous active efflux of norfloxacin in susceptible Escherichia coli.

Authors:  S P Cohen; D C Hooper; J S Wolfson; K S Souza; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

5.  Membrane potential and gentamicin uptake in Staphylococcus aureus.

Authors:  S M Mates; E S Eisenberg; L J Mandel; L Patel; H R Kaback; M H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  Susceptible Escherichia coli cells can actively excrete tetracyclines.

Authors:  L M McMurry; D A Aronson; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

7.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

8.  Lipopolysaccharide composition of three strains of Haemophilus influenzae.

Authors:  T R Parr; L E Bryan
Journal:  Can J Microbiol       Date:  1984-09       Impact factor: 2.419

9.  Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin.

Authors:  L E Bryan; S Kwan
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

10.  Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  L E Bryan; K O'Hara; S Wong
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.